TECH – bio-techne corp (US:NASDAQ)

News

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return [Yahoo! Finance]
Bio-Techne (NASDAQ:TECH) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Bio-Techne (NASDAQ:TECH) was given a new $72.00 price target on by analysts at Deutsche Bank Aktiengesellschaft.
Here's Why BioTechne (TECH) Traded Lower in Q3 [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com